- Home
- EPAC vs ZLAB Comparison
EPAC vs ZLAB Comparison
Compare EPAC & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPAC
- ZLAB
- Stock Information
- Founded
- EPAC 1910
- ZLAB 2013
- Country
- EPAC United States
- ZLAB China
- Employees
- EPAC N/A
- ZLAB N/A
- Industry
- EPAC Industrial Machinery/Components
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- EPAC Technology
- ZLAB Health Care
- Exchange
- EPAC Nasdaq
- ZLAB Nasdaq
- Market Cap
- EPAC 2.3B
- ZLAB 3.6B
- IPO Year
- EPAC N/A
- ZLAB 2017
- Fundamental
- Price
- EPAC $37.72
- ZLAB $32.54
- Analyst Decision
- EPAC Buy
- ZLAB Buy
- Analyst Count
- EPAC 1
- ZLAB 5
- Target Price
- EPAC $53.00
- ZLAB $54.28
- AVG Volume (30 Days)
- EPAC 527.7K
- ZLAB 781.8K
- Earning Date
- EPAC 06-26-2025
- ZLAB 08-05-2025
- Dividend Yield
- EPAC 0.11%
- ZLAB N/A
- EPS Growth
- EPAC 7.49
- ZLAB N/A
- EPS
- EPAC 1.63
- ZLAB N/A
- Revenue
- EPAC $608,099,000.00
- ZLAB $418,326,000.00
- Revenue This Year
- EPAC $6.24
- ZLAB $44.07
- Revenue Next Year
- EPAC $5.86
- ZLAB $49.13
- P/E Ratio
- EPAC $23.12
- ZLAB N/A
- Revenue Growth
- EPAC 2.82
- ZLAB 43.72
- 52 Week Low
- EPAC $36.78
- ZLAB $16.01
- 52 Week High
- EPAC $51.91
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- EPAC 29.79
- ZLAB 40.19
- Support Level
- EPAC $37.33
- ZLAB $34.26
- Resistance Level
- EPAC $38.54
- ZLAB $35.72
- Average True Range (ATR)
- EPAC 1.31
- ZLAB 1.12
- MACD
- EPAC -0.37
- ZLAB -0.54
- Stochastic Oscillator
- EPAC 4.75
- ZLAB 3.83
About EPAC Enerpac Tool Group Corp.
Enerpac Tool Group Corp provides high-precision tools, controlled-force products, and solutions for precise heavy lifting. The company has one reportable segment, the Industrial Tools & Services (IT&S) Segment. The IT&S segment is engaged in the design, manufacture, and distribution of branded hydraulic and mechanical tools and in providing services and tool rental to the refinery/petrochemical; general industrial; industrial maintenance, repair, and operations (MRO); machining & manufacturing; power generation; infrastructure; mining; and other markets. Geographically, the company has operations in Algeria, Australia, Brazil, France, Germany, Kazakhstan, India, Italy, Japan, Norway, Poland, Saudi Arabia, Singapore, South Africa, South Korea, Spain, and the United Arab Emirates.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.